Anticancer Bioscience is building a focused oncology company grounded in rigorous science and disciplined execution. Our work is centered on the discovery and clinical development of synthetic lethality–based therapies that address fundamental vulnerabilities in cancer.
The company operates teams across China (headquarters), India, Australia, the United Kingdom, and the United States, reflecting the global scope of our research and clinical activities.
We are expanding a multidisciplinary team encompassing biology, chemistry, translational science, clinical development, and operations. We value diversity of background and perspective and seek individuals motivated by scientific rigor, accountability in execution, and long-term impact.
Opportunities are available across scientific, clinical, and operational functions.
